Has Friedrich Boettner, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,870,964 in general payments to Friedrich Boettner, MD across 275 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Friedrich Boettner, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Friedrich Boettner, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Friedrich Boettner, MD

Adult Reconstructive Orthopaedic Surgery · New York, NYNPI 1205945409

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $2,817,786 of the $2,870,964 with a category attached, or 98.1%. Ortho Development Corporation accounts for 84.8% of it on its own, with 11 other manufacturers making up the rest. Among adult reconstructive orthopaedic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,870,964in general payments, 2019–2025

Across 275 payments — averaging $10,440 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Ortho Development Corporation$2.4M
Smith+Nephew$389K
Medacta USA, Inc.$26K
Medical Device Business Services, Inc.$13K
Johnson & Johnson$4K
Medtronic$3K
plus $2K from 6 others

$11,200in research payments, 2019–2025

Across 6 payments — averaging $1866.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medical Device Business Services, Inc.$11K

What the payments were for

Royalty or licence$2,817,78698%
Consulting fees$17,1001%
Speaking & faculty fees$2,7000%
Travel & lodging$26,2281%
Food & beverage$3,7560%
Gifts$1140%
Other$3,2800%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Ortho Development Corporation	187	$2,433,938
Smith+Nephew	21	$388,779
Medacta USA, Inc.	33	$25,918
Medical Device Business Services, Inc.	12	$13,294
Johnson & Johnson(2 entities)	8	$4,111
Medtronic	6	$3,019
Globus Medical	2	$1,335
Linkbio Corp	1	$192
Zimmer Biomet	2	$137
Engage Uni, LLC	1	$114
Aesculap Implant Systems, LLC	1	$113
Stryker	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

BKS TriMax$1,880,961
Balanced Knee System$398,126
Legion$223,358
LEGION TKS$165,301
Alpine Hip System$99,252
Alpine$51,061
Legion Revision$22,040
AMISTEM$20,571
ACTIS$11,397
CORAIL$11,025
PINNACLE$11,025
AQUAMANTYS$2,965
NextAR Hip$2,837
Proven Gen-Flex PS Knee System$1,335
GMK SPHERE$1,327
QUADRA$880
Velys$529
ATTUNE$411
Balanced Knee Revision System$170
Kincise$150

How this compares

$2,870,964 in reported general payments places this provider in the 95th percentile of 85 adult reconstructive orthopaedic surgery providers in New York.

See all adult reconstructive orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024

$295,531

Medicare patients

447

Services billed

2,347

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Celecoxib	76	$1,327
Diclofenac Sodium	42	$312
Omeprazole	38	$200
Meloxicam	50	$165
Oxycodone Hcl	20	$143
Clindamycin Hcl	11	$102
Amoxicillin	31	$84

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in New York

Seth JerabekNew York$7.1M
Jose RodriguezNew York$3.4M
Jonathan VigdorchikNew York$2.3M
William LongNew York$1.5M
Peter SculcoNew York$1.5M
Roshan ShahNew York$1.3M
Herbert CooperNew York$1.3M
Matthew AustinNew York$986K
Patrick MeereNew York$191K
Eytan DebbiNew York$168K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →